As of 31 Dec 2025, 42 institutional investors reported holding $303,483,670 in principal (par value) of MIRUM PHARMACEUTICALS INC - NOTE 4.000% 5/0.
| Period | Principal | Value | Change | Price (% of par) (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | $303,483,670 | $784,435,556 | -$60,590,670 | 258.07% | 42 |
| 2025 Q3 | $307,636,670 | $740,546,108 | +$45,284,221 | 240.15% | 41 |
| 2025 Q2 | $300,281,225 | $533,109,908 | -$1,145,567 | 177.38% | 41 |
| 2025 Q1 | $300,918,225 | $490,695,428 | +$8,812,607 | 162.6% | 38 |
| 2024 Q4 | $296,243,895 | $450,609,974 | -$6,400,893 | 152.25% | 35 |
| 2024 Q3 | $296,659,945 | $437,996,520 | -$2,614,830 | 146.89% | 36 |
| 2024 Q2 | $297,525,608 | $401,072,370 | +$398,393,673 | 133.99% | 30 |